Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jan Osinga

Showing results (1-10 of 19) with videos related to

Pageof 2
Sort By:
American Journal of Medical Genetics|March 14, 2002
ABCD syndrome is caused by a homozygous mutation in the EDNRB geneJoke B G M Verheij, Jürgen Kunze, Jan Osinga, et al.
Gastroenterology|October 28, 2010
Variants in RET associated with Hirschsprung's disease affect binding of transcription factors and gene expressionYunia Sribudiani, Marco Metzger, Jan Osinga, et al.
Cancer Research|May 27, 2010
Histone methyltransferase gene SETD2 is a novel tumor suppressor gene in clear cell renal cell carcinomaGerben Duns, Eva van den Berg, Inge van Duivenbode, et al.
Plos One|December 29, 2010
Mutations in SCG10 are not involved in Hirschsprung diseaseMaria M M Alves, Jan Osinga, Joke B G M Verheij, et al.
American Journal of Human Genetics|September 6, 2002
A rare haplotype of the RET proto-oncogene is a risk-modifying allele in hirschsprung diseasePaola Griseri, Barbara Pesce, Giovanna Patrone, et al.
Neoplasia (New York, N.Y.)|June 14, 2016
Functional Studies on Primary Tubular Epithelial Cells Indicate a Tumor Suppressor Role of SETD2 in Clear Cell Renal Cell CarcinomaJun Li, Joost Kluiver, Jan Osinga, et al.
The Journal of Clinical Endocrinology and Metabolism|April 8, 2011
The effects of four different tyrosine kinase inhibitors on medullary and papillary thyroid cancer cellsHans H G Verbeek, Maria M Alves, Jan-Willem B de Groot, et al.
European Journal of Human Genetics : EJHG|May 13, 2004
Localizing a putative mutation as the major contributor to the development of sporadic Hirschsprung disease to the RET genomic sequence between the promoter region and exon 2Grzegorz M Burzynski, Ilja M Nolte, Jan Osinga, et al.
Cellular Physiology and Biochemistry : International Journal of Experimental Cellular Physiology, Biochemistry, and Pharmacology|September 6, 2018
MicroRNA High Throughput Loss-of-Function Screening Reveals an Oncogenic Role for miR-21-5p in Hodgkin LymphomaYe Yuan, Fubiao Niu, Ilja M Nolte, et al.
American Journal of Human Genetics|March 11, 2005
Identifying candidate Hirschsprung disease-associated RET variantsGrzegorz M Burzynski, Ilja M Nolte, Agnes Bronda, et al.
Pageof 2

Showing results (1-10 of 19) with videos related to

Sort By:
Pageof 2
American Journal of Medical Genetics|March 14, 2002
ABCD syndrome is caused by a homozygous mutation in the EDNRB geneJoke B G M Verheij, Jürgen Kunze, Jan Osinga, et al.
Gastroenterology|October 28, 2010
Variants in RET associated with Hirschsprung's disease affect binding of transcription factors and gene expressionYunia Sribudiani, Marco Metzger, Jan Osinga, et al.
Cancer Research|May 27, 2010
Histone methyltransferase gene SETD2 is a novel tumor suppressor gene in clear cell renal cell carcinomaGerben Duns, Eva van den Berg, Inge van Duivenbode, et al.
Plos One|December 29, 2010
Mutations in SCG10 are not involved in Hirschsprung diseaseMaria M M Alves, Jan Osinga, Joke B G M Verheij, et al.
American Journal of Human Genetics|September 6, 2002
A rare haplotype of the RET proto-oncogene is a risk-modifying allele in hirschsprung diseasePaola Griseri, Barbara Pesce, Giovanna Patrone, et al.
Neoplasia (New York, N.Y.)|June 14, 2016
Functional Studies on Primary Tubular Epithelial Cells Indicate a Tumor Suppressor Role of SETD2 in Clear Cell Renal Cell CarcinomaJun Li, Joost Kluiver, Jan Osinga, et al.
The Journal of Clinical Endocrinology and Metabolism|April 8, 2011
The effects of four different tyrosine kinase inhibitors on medullary and papillary thyroid cancer cellsHans H G Verbeek, Maria M Alves, Jan-Willem B de Groot, et al.
European Journal of Human Genetics : EJHG|May 13, 2004
Localizing a putative mutation as the major contributor to the development of sporadic Hirschsprung disease to the RET genomic sequence between the promoter region and exon 2Grzegorz M Burzynski, Ilja M Nolte, Jan Osinga, et al.
Cellular Physiology and Biochemistry : International Journal of Experimental Cellular Physiology, Biochemistry, and Pharmacology|September 6, 2018
MicroRNA High Throughput Loss-of-Function Screening Reveals an Oncogenic Role for miR-21-5p in Hodgkin LymphomaYe Yuan, Fubiao Niu, Ilja M Nolte, et al.
American Journal of Human Genetics|March 11, 2005
Identifying candidate Hirschsprung disease-associated RET variantsGrzegorz M Burzynski, Ilja M Nolte, Agnes Bronda, et al.
Pageof 2